循环补体因子H相关蛋白5水平促进IgA肾病的发生与进展
该研究比较了1126例IgA肾病患者与153名健康对照的循环FHR-5水平,发现患者FHR-5显著升高,且高FHR-5水平与eGFR下降、高血压及严重牛津T、C评分相关,并独立增加eGFR下降30%或终末期肾病风险。
要点
- IgA肾病患者循环FHR-5水平显著高于健康人。
- 高FHR-5水平与较低eGFR、高血压及严重牛津T/C评分相关。
- FHR-5是IgA肾病进展的独立危险因素。
核心结论
- 循环FHR-5水平是IgA肾病进展的独立危险因素。
研究设计与样本
- 比较1126例规律随访的IgA肾病患者与153名无亲缘健康个体的循环FHR-5水平。
主要发现
- IgA肾病患者循环FHR-5中位水平为4.55 μg/ml(IQR 3.58–5.85),健康人为3.19 μg/ml(IQR 2.55–3.92)。
- 较高FHR-5水平与较低eGFR、高血压及严重牛津T和C评分相关。
- FHR-5每增加1个标准差(自然对数转换后),eGFR下降30%或终末期肾病的风险比为1.226(95%CI 1.106–1.359)。
临床怎么用
- 检测循环FHR-5水平可能有助于识别IgA肾病进展高风险患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IgA nephropathy (IgAN) is a disease associated with activation of the complement system. But the factors influencing complement activation in IgAN are not fully understood. Complement factor H (FH) is an essential negative regulator of complement C3 activation. Complement factor H-related protein (FHR)-5 shares high sequence similarity with factor H. However, unlike factor H, on binding to activated C3 it enables further activation to proceed. Previously, we reported the contribution of rare variants of the CFHR5 gene to IgAN susceptibility. Here we compared circulating levels of FHR-5 in 1126 patients with IgAN and regular follow-up with those of 153 unrelated healthy individuals to explore the relationship of FHR-5 levels with IgAN development and progression. Circulating FHR-5 levels were significantly elevated in patients with IgAN compared to healthy individuals (median 4.55 [interquartile range 3.58 to 5.85] μg/ml vs 3.19 [interquartile range 2.55 to 3.92] μg/ml). Higher circulating FHR-5 levels were associated with a lower estimated glomerular filtration rate, hypertension, and severe Oxford-T and Oxford-C scores. High FHR-5 levels were independently and significantly associated with a risk of developing either a 30% decline in the estimated glomerular filtration rate or end-stage renal disease (hazard ratio, per standard deviation increment of natural square root transformed FHR-5 of 1.226; 95% confidence interval: 1.106-1.359). Thus, the circulating FHR-5 level is an independent risk factor for IgAN progression.
引用
- Zhu L, Guo WY, Shi SF, et al. Circulating complement factor H-related protein 5 levels contribute to development and progression of IgA nephropathy. Kidney Int. 2018. PMID: 29759419. doi:10.1016/j.kint.2018.02.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。